Abstract:Natural killer (NK) cells play a crucial role in antitumoral and antiviral responses. Yet, cancer cells can alter themselves or the microenvironment through the secretion of cytokines or other factors, hindering NK cell activation and promoting a less cytotoxic phenotype. These resistance mechanisms, often referred to as the "hallmarks of cancer" are significantly influenced by the activation of oncogenes, impacting most, if not all, of the described hallmarks. Along with oncogenes, other types of genes, the tumor suppressor genes are frequently mutated or modified during cancer. Traditionally, these genes have been associated with uncontrollable tumor growth and apoptosis resistance. Recent evidence suggests oncogenic mutations extend beyond modulating cell death/proliferation programs, influencing cancer immunosurveillance. While T cells have been more studied, the results obtained highlight NK cells as emerging key protagonists for enhancing tumor cell elimination by modulating oncogenic activity. A few recent studies highlight the crucial role of oncogenic mutations in NK cell-mediated cancer recognition, impacting angiogenesis, stress ligands, and signaling balance within the tumor microenvironment. This review will critically examine recent discoveries correlating oncogenic mutations to NK cell-mediated cancer immunosurveillance, a relatively underexplored area, particularly in the era dominated by immune checkpoint inhibitors and CAR-T cells. Building on these insights, we will explore opportunities to improve NK cell-based immunotherapies, which are increasingly recognized as promising alternatives for treating low-antigenic tumors, offering significant advantages in terms of safety and manufacturing suitability.

Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

Natural Killer Cells: Tumor Surveillance and Signaling

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy

Natural killer cells in cancer biology and therapy

The role of the natural killer (NK) cell modulation in breast cancer incidence and progress

Exploiting NK Cell Surveillance Pathways for Cancer Therapy

Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Natural killer cells in cancer immunotherapy

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization

NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances

Shaping of NK Cell Responses by the Tumor Microenvironment

Targeting Natural Killer Cells for Tumor Immunotherapy

The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies

Natural killer cell-based cancer immunotherapy: from basics to clinical trials

Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies

Roles of natural killer cells in immunity to cancer, and applications to immunotherapy